# A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment

> **NCT01710514** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 108 (actual)

## Conditions studied

- Luteal Hormone Supplementation

## Interventions

- **DRUG:** FE 999913 vaginal tablet

## Key facts

- **NCT ID:** NCT01710514
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2014-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01710514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01710514, "A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01710514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*